Evofem Biosciences, Inc. EVFM
Set alert
0.01 USD 0.00 0.00%
As of Nov 2, 3:50 PM ET
0.006 Day range 0.0066
0.001 52-week range 0.014
- YTD
- -40.00%
- 1 year
- -40.00%
- Open
- 0.0066
- Prev close
- 0.006
- Mkt cap
- 795.18K
- Vol
- 14.13K
- Avg vol
- 169.79K
- EPS
- -0.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.006
- High
- 0.0066
- Forward P/E
- -0.48
- Beta
- -1.68
- Short ratio
- 0.19
- Inst. own
- 9.67%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.74126
- 200-d avg
- 3.61
- 1y target
- 11.05
5D chart
Signals (20)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2:00 PM | 11 hours ago |
| RSI: Oversold | Nov 2, 2:00 PM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 1:25 PM | 11 hours ago |
| RSI: Overbought | Nov 2, 12:15 PM | 12 hours ago |
| MACD: Buy Signal | Oct 30, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:35 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 11:35 AM | 3 days ago |
| RSI: Overbought | Oct 30, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 11:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 4 days ago |
| RSI: Oversold | Oct 29, 10:25 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:50 AM | 5 days ago |
| RSI: Overbought | Oct 28, 10:25 AM | 5 days ago |
Financial health
Altman Z-Score
-182.94 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 4.3×
FY 2016 5y median -0.0× FY 2025
P/S 0.1×
FY 2016 5y median 0.1× FY 2025
P/B -0.0×
FY 2016 5y median -0.0× FY 2025
P/FCF -0.6×
FY 2016 5y median -0.2× FY 2025
EV/EBITDA 26.7×
FY 2016 5y median -0.9× FY 2025
EV/Sales 2.7×
FY 2016 5y median 2.7× FY 2025
FCF Yield -170.0%
FY 2016 5y median -408.3% FY 2025
Profitability
Gross Margin 74.7%
FY 2016 5y median 73.8% FY 2025
Operating Margin 7.1%
FY 2016 5y median -98.0% FY 2025
Net Margin 1.9%
FY 2016 5y median -45.8% FY 2025
ROE -0.6%
FY 2016 5y median 12.4% FY 2025
ROIC -14.2%
FY 2016 5y median 71.7% FY 2025
ROA 1.9%
FY 2016 5y median -37.2% FY 2025
Growth (YoY)
Revenue 4.2%
FY 2016 FY 2025
Operating Income 118.7%
FY 2016 FY 2025
EPS (diluted) 100.0%
FY 2016 FY 2025
Free Cash Flow 48.8%
FY 2016 FY 2025
Financial Health
Current Ratio 0.2×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.2×
FY 2016 5y median 0.1× FY 2025
Debt / Equity -0.8×
FY 2016 5y median -0.8× FY 2025
Net Debt / EBITDA 26.1×
FY 2016 5y median -0.8× FY 2025
Interest Coverage 0.5×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 10.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 29.9%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
